Glioblastoma multiforme (GBM), the most common and deadly brain cancer, exemplifies the
paradigm that cancers grow with help from an immunosuppressive tumor microenvironment …

Glioma is the most common primary brain cancer, and half of patients present a diagnosis of
glioblastoma (GBM), its most aggressive and lethal form. Conventional therapies, including …

Glioblastoma (GBM) is the most common primary brain tumor in adults an carries and carries
a terrible prognosis. The current regiment of surgical resection, radiation, and chemotherapy …

Glioblastoma (GBM), the predominant and primary malignant intracranial tumor, poses a
formidable challenge due to its immunosuppressive microenvironment, thereby confounding …

Glioblastoma (GBM) is the most aggressive and lethal form of brain tumor in human adults.
Myeloid-lineage cells, including macrophages, microglia, myeloid-derived suppressor cells …

Glioblastoma (GBM) is the most common and lethal malignant tumor of the central nervous
system in adults. Conventional therapies, including surgery, radiotherapy, and …

Gliomas are brain tumors that arise from neuroglial progenitor cells in the brain, which have
an annual incidence rate of around six per 100,000 people in the US (Ostrom et al., 2013) …

Gliomas are intrinsic brain tumors that originate from glial cells. Glioblastoma (GBM) is the
most aggressive glioma type and resistant to immunotherapy, mainly due to its unique …

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous group of myeloid
progenitor and precursor cells at different stages of differentiation, which play an important …

Glioblastoma is a highly lethal brain cancer with a median survival rate of less than 15
months when treated with the current standard of care, which consists of surgery …